
Crēdo ProEnvision Software 2.0, company says, expected to improve the customer experience for cold chain clients
Crēdo ProEnvision Software 2.0, company says, expected to improve the customer experience for cold chain clients
Accreditation further extends CDMO's viral vector manufacturing capacity
Acquisition expected to be finalized in April
Survey conducted by HDA reveals thought process of manufacturers, distributors, and 3PLs
Moderna, Pfizer, and BioNTech seeking FDA approval for fourth dose of their respective shots
Among benefits, Expanded Access software can reportedly help design more effective clinical trials and capture RWD
Platform combines data, software, and insights “into single ecosystem.”
Latest report suggests a slower rate of growth and constrained capacity
Shipment from Basel, Switzerland, to JFK airport, New York, consisted of three Releye RAP units and two RAP e2 units.
Acquisition of data-driven prescription drug benefit and affordability company will ”help patients overcome financial barriers to starting and staying on therapy.”
Acquires MarketShare Movers, as company aims to provide patients with affordability services
CDMO’s Chenôve facility receives investment from French government
Deal expected to help expand its API production services
Agreement establishes company’s first mRNA manufacturing facility in Africa
Healthcare market research and insights company will become part of Ashfield Advisory.
The deal features a long-term supply and production agreement between the parties
Expansion features 11 new cGMP labs at Durham, NC location
If given green light by European Commission, vaccine dose will be less than that of adolescents
GTS improvements include additional data integrity protection, greater Level 1 and 2 equipment compatibility
The latest people news happenings over the past month
New consortium provides integrated solution with specialist services, from biologics discovery to clinical and commercial manufacturing.
The parties are partnering up to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies
Advance purchase agreement is for up to 200 million doses of Nuvaxovid
Discussions will revolve around fortifying the pharma supply chain
Turnkey centers will promote scalable vaccine production for an end-to-end manufacturing network for mRNA-based vaccines in Africa
CDMO obtains both Vibalogics and Arranta Bio to increase presence in the sector
Will establish presence in Belgium, Denmark, Norway, the Netherlands, Poland and Sweden
Plans are underway to build Scottish fill-finish center, renovate API facility in England
Agreement provides pharma firms with an RWD and commercialization solution